WebFeb 27, 2024 · Genprex, Inc. Announces $4 Million Registered Direct Offering With a Single, Healthcare-Focused Institutional Investor PR Newswire AUSTIN, Texas, Feb. 27, 2024 AUSTIN, Texas, Feb. 27, 2024 /PRNewsw... WebApr 6, 2024 · finance.yahoo.com - March 8 at 11:05 AM. Genprex, Inc. Announces $4 Million Registered Direct Offering With a Single, Healthcare-Focused Institutional Investor. finance.yahoo.com - February 27 at 9:05 PM. Genprex unveils groundbreaking data from primate study on its novel gene therapy to treat Type 1 diabetes at ATTD 2024 in Berlin.
What date does GENPREX
WebFeb 27, 2024 · Genprex Inc GNPX shares are trading lower by 19.12% to $1.10 during Monday's pre-market session. The company announced a $4 million registered direct offering with an institutional investor. WebFeb 23, 2024 · Our common stock is listed on The Nasdaq Capital Market under the symbol “GNPX.” On February 24, 2024, the last reported sale price of our common stock on The Nasdaq Capital Market was $1.36 per share. ... If you purchase securities in this offering, you may also experience future dilution as a result of future equity offerings. In order to ... gov statutory holidays
GNPX Stock Price Genprex Inc. Stock Quote (U.S.: …
WebApr 12, 2024 · What is Genprex's consensus rating and price target? According to the issued ratings of 1 analysts in the last year, the consensus rating for Genprex stock is Buy based on the current 1 buy rating for GNPX. The average twelve-month price prediction for Genprex is $3.00 with a high price target of $3.00 and a low price target of $3.00. WebFeb 27, 2024 · The closing of the offering is expected to occur on or about March 1, 2024, subject to the satisfaction of customary closing conditions.The gross proceeds from the … WebDec 31, 2024 · Genprex, Inc. rapporteerde winstresultaten voor het volledige jaar eindigend op 31 december 2024. Voor het hele jaar rapporteerde het bedrijf een nettoverlies van 23,74 miljoen USD, vergeleken met... 13 april 2024 children\u0027s health food allergy